Lepage, Tristan M.
Campillo, Jérémy T.
Louya, Frédéric
Bikita, Paul
Missamou, François
Hemilembolo, Marlhand C.
Pion, Sébastien D. S.
Boussinesq, Michel
Chesnais, Cédric B.
Funding for this research was provided by:
Agence Nationale de la Recherche (18-CE17-0008)
Article History
Received: 22 July 2024
Accepted: 14 September 2024
First Online: 8 November 2024
Declarations
:
: This work was nested in a trial aimed at evaluating the safety and efficacy of single doses of levamisole in individuals infected with <i>L. loa</i>. This trial was approved by the Committee on Ethics in Health Sciences Research (No. 226/MRSIT/IRSSA/CERRSSA) and an Administrative Authorization (No. 469/MSP/CAB/UCPP-19) was released by the Ministry of Health and Population of the Congo.
: Not applicable.
: The authors declare no competing interests.